Highlights
==========

-   Nerve growth factor increased differentiation of human dental pulp stem cells into cholinergic neurons.

-   Human dental pulp stem cells were differentiated into the cholinergic neurons using βME.

-   The optimal dose for nerve growth factor to induce cholinergic neural differentiation was 50 ng/mL.

Plain Language Summary
======================

Cell therapy is a therapeutic approach in neuroregenerative medicine. Cholinergic neurons have an essential role in emotions, mobility, and autonomic systems. Here, we used human dental pulp stem cells (hDPSCs) to produce cholinergic neurons using some growth factors, such as β-mercaptoethanol and nerve growth factor (NGF). We found that β-mercaptoethanol and NGF increased the differentiation of hDPSCs into cholinergic neurons. Also, the optimal dose for NGF to induce cholinergic neural differentiation was 50 ng/mL. The protocol of this study can be used in cytotherapy in degenerative diseases of the nervous system and spinal cord injury.

1.. Introduction
================

Nowadays, cell therapy is highly regarded as one of the therapeutic methods for nervous system injuries ([@B39]; [@B17]). Different types of cells, such as embryonic stem cells (ESCs), adult stem cells, and umbilical cord stem cells have been studied for transplantation into the nervous system ([@B10]; [@B8]). The cholinergic neurons are used for the treatment of motor neuron degeneration ([@B2]; [@B9]) and Alzheimer disease ([@B49]).

In previous studies, cholinergic neurons have been generated from ESCs and induced Pluripotent Stem Cells (iPSCs). Because of the allogeneic, tumorigenic, and ethical problems, using other mesenchymal stem cells has been suggested. However, Bone Marrow Stromal stem Cells (BMSCs) and Adipose-Derived Stem Cells (ADSCs) have been applied for neuronal differentiation ([@B18]; [@B38]; [@B41]; [@B43]; [@B3]). Interestingly, Human Dental Pulp Stem Cells (hDPSCs) have a high capacity to differentiate into neurons. It has shown that transplantation of the cholinergic neurons into animal models could increase the survival rate of laboratory animals ([@B33]). Since the identification of hDPSCs by [@B23], other researchers have investigated hDPSCs ability to differentiate into other cell lines ([@B27]; [@B6]). Many studies have revealed DPSCs differentiation potential into neural cells in vitro ([@B29]; [@B15]). Moreover, after injection into the chicken and rat brain, hDPSCs can express neural markers and respond to brain neurotrophic factors ([@B28]; [@B34]). Although in the neuronal culture medium, Mesenchymal Stem Cells (MSCs) are differentiated into neurons, astrocytes, and oligodendrocytes ([@B22]; [@B16]; [@B3]), their efficiency is very low and predictable. Recently, hDPSCs due to their embryonic origin have become a promising source for cell therapy ([@B22]).

The hDPSCs originate from neural crest cells and have neuronal specifications ([@B22]; [@B16]; [@B4]). They also are known as ectomesenchymal cellsderived from the ectoderm around the neural tube and migrate to the areas within the tooth and dental pulp leading to a mesenchymal phenotype. MSCs are not rejected by the immune system and present no ethical issues ([@B1]; [@B24]). Therefore, these cells are suitable for cell therapy in nervous system diseases. In a study, due to the secretion of neuronal factors, Dental Pulp Stem Cells (DPSC) increased the survival of tyrosine hydroxylase neurons in the culture medium ([@B24]). In normal circumstances and without neural lineage induction, hDPSCs could express some neuronal factors, such as nestin and Glial Fibrillary Acidic Protein (GFAP) at the level of genes and proteins ([@B21]).

In the neural induction medium, hDPSCs can express the specific markers for post-mitotic mature neurons, like Neuronal Nuclear antigen (NeuN) ([@B32]; [@B43]). Although DPSC can become Neural-Like Cells (NLCs) in differentiation medium, it cannot be differentiated completely ([@B7]). In previous studies on DPSC differentiation, 5% of hDPSCs has differentiated into steroid cells expressing GFAP ([@B42]). In another study, about 53% of choline acetyltransferase (ChAT)-positive motor neurons were generated from hDPSCs ([@B20]).

It seems that the hDPSCs can differentiate into specific subtypes of neurons under appropriate conditions. The current research aimed to create ChAT-positive cells from hDPSCs during two phases of preinduction and induction by β-mercaptoethanol (βME) and Nerve Growth Factor (NGF), respectively.

2.. Methods
===========

2.1.. Isolation and cultivation of hDPSCs
-----------------------------------------

In this study, hDPSCs were isolated from the human third molar. Healthy teeth without cavities were collected from 18--25 years old patients referred to the dental clinic of the Mazandaran University of Medical Sciences. The informed consent was obtained from the participants, and the research was approved by the Human Ethics Committee of Mazandaran University of Medical Sciences. Teeth were washed in Phosphate-Buffered Saline (PBS). To disinfect the teeth, iodine (povidone-iodine 10%, Pejnan, Iran) was used for 5 min. Then, using a separator and surgery cutter, root and dentin were broken and pulp tissue was isolated by sterile forceps. Pulp tissue digestions were done by scalpel and trypsin 0.25% (Gibco, USA). Pulp tissues with trypsin and DMEM/F12 (Gibco-Life Technologies, Canada) were poured in a falcon tube and kept in an incubator for 5 min. In the next step, the falcon tube was centrifuged, the supernatant was removed and pulp tissues were transferred into cell culture flasks containing medium and incubated at 37° C with 5% CO ~2~ and 95% humidity. The cell culture flask was examined every 2--3 days. After 3--4 passages, hDPSCs were used ([@B23]).

2.2.. Differentiation of hDPSCs into neurons
--------------------------------------------

For preinduction step, hDPSCs were seeded into 6-well plates. After 24 h, 1 mM of βME (Sigma) was added into the wells and kept for 48 h. At the induction phase, the optimal dose of NGF (R & D Systems, USA) was evaluated using a dose-response (1, 25, 50, and 100 ng/mL) and time-course (2 and 7 days) evaluation, in which the preinduced hDPSCs were incubated with this protocol. Morphological analysis of differentiating cells was assessed in different groups by an inverted microscope (Nikon, Eclipse-TS100), dimethylthiazolyl diphenyl tetrazolium bromide (MTT) assay, and immunocytochemistry technique.

2.3.. MTT assay
---------------

To achieve the optimal dose of NGF, the viability of hDPSCs, preinduced, and induced cells were assessed by MTT assay. Briefly, the 96-well plates were incubated with MTT (5 mg/mL in PBS, Sigma-Aldrich) for 3 h at 37 °С. Formazan insoluble crystals were then solved in dimethyl sulfoxide (DMSO, Sigma). The absorbance of formazan products was determined by the ELISA plate reader (Bio Tek, USA) at 570 nm ([@B22]).

2.4.. Immunocytochemistry
-------------------------

After the third passage, hDPSCs were assessed for Oct-4 (a pluripotency stem cell marker), CD73 (mesenchymal stromal cell marker), CD31 (endothelial cell marker), and CD34 (hematopoietic stem cells marker) by immunocytochemical assessment. Immunocytochemistry technique evaluated immunoreaction of hDPSCs, preinduced, and induced cells to nestin, neurofilament 160 (NF160), microtubule-associated protein 2 (MAP2), and ChAT.

Cells were washed three times with PBS for 5 min and then fixed in 4% paraformaldehyde (Sigma-Aldrich) for 15 min. Next, they were rewashed with PBS. In the next step, the cells were permeabilized with 1% Triton X-100 (Sigma-Aldrich) for 30 min and blocked with bovine serum albumin (Sigma-Aldrich) for 45 min. The cells were incubated with the rabbit anti-mouse secondary antibody conjugated with FITC (1:100; Millipore) for 2 h at room temperature. The cells were then rinsed twice in PBS for 15 min and counterstained with propidium iodide to visualize the nuclei. They were rewashed in PBS and examined using a fluorescence microscope (Nikon, Eclipse-TE600, Japan). All antibodies were prepared in mouse, and the following dilutions were used as follows: mouse anti-CD31 monoclonal antibody (1:200; Millipore), mouse anti-CD73 monoclonal antibody (1:300; Millipore), mouse anti-CD34 monoclonal antibody (1:300; Millipore), mouse anti-Oct4 monoclonal antibody (1:400), mouse anti-nestin monoclonal antibody (1:300; Millipore), mouse anti-neurofilament 160 kDa (anti-NF160) monoclonal antibody (1:300; Millipore), mouse anti-MAP2 monoclonal antibody (1:500, Abcam system), and mouse anti-ChAT monoclonal antibody (1:500; Abcam system).

The number of immunopositive cells for neuronal markers was obtained using the captures of immunostained cultures, counted, and then divided by the total number of cells (propidium iodide-stained cells) in at least five random nonoverlapping selected fields, where 500 cells were counted in three independent cultures. The results were expressed as Mean±SD.

2.5.. Statistical analysis
--------------------------

One-way Analysis of Variance (ANOVA) and Tukey's posthoc test were used for data analysis in SPSS V. 13.0. P-values of less than 0.05 were considered significant.

3.. Results
===========

3.1.. hDPSCs culture and characterization
-----------------------------------------

After enzymatic digestion, hDPSCs were plated onto a T25 culture flask. The cells were attached to the bottom of the flask and had a uniform population of fibroblast-like cell bodies and appendages. hDPSCs were strongly positive for Oct-4 as a stem cell pluripotency marker and CD73 as a mesenchymal stromal cell marker. However, they were negative for CD31 as an endothelial cell marker and CD34 as a hematopoietic stem cell marker ([Figure 1](#F1){ref-type="fig"}).

![Immunostaining of cultured hDPSCs\
A, B, C, and D. represent immunostaining of Oct-4, CD73, CD31, and CD34, respectively. hDPSCs were immunolabeled with the primary antibody, incubated with FITC-conjugated secondary antibody, and counter-stained using propidium iodide (Scale bars: 50 μm).\
hDPSCs: Human Dental Pulp Stem Cells](BCN-10-609-g001){#F1}

3.1.. hDPSCs differentiation
----------------------------

To find out the optimal dose and induction time of NGF, the preinduced cells were exposed to various concentrations of NGF (1, 25, 50, and 100 ng/mL) for 7 days ([Figure 2](#F2){ref-type="fig"}). Then, the cell viability was investigated 7 days after NGF treatment. The results of the MTT assay showed that the viability of the cells at 100 ng/mL concentration was significantly lower than other doses (P\<0.05) ([Figure 2](#F2){ref-type="fig"}).

![A histogram indicating the dose-response experiment\
The dose-response human dental pulp stem cells-derived cholinergic-like neurons viability at different concentrations of NGF (1, 25, 50, and 100 ng/mL) after 7 days detected by MTT assay. Each column represents the average measurement from five replicates. The asterisk shows significant differences compared with the other groups (P\<0.05).\
NGF: Nerve Growth Factor; MTT: Dimethylthiazolyl Diphenyl Tetrazolium Bromide](BCN-10-609-g002){#F2}

Before hDPSCs induction, they expressed nestin (neural stem cells \[NSCs\] marker) by less than 10% (P\<0.05). They also expressed other neuronal markers, such as NF160 (a neuronal intermediate filament marker), microtubule-associated protein 2 (MAP2a marker for neuronal differentiation), and ChAT (a cholinergic neuron marker) by less than 1% ([Figure 2](#F2){ref-type="fig"}). Following preinduction with βME, the expression rate of nestin, NF160, MAP2, and ChAT increased (P\<0.05; [Figure 3](#F3){ref-type="fig"}).

![Histogram of the mean percentages of the immunoreactive cells to nestin\
NF160, MAP2, and ChAT (Hatched lines pattern, chessboard pattern, white and black solid columns, respectively) of the hDPSCs, preinduced, and induced cells with 50 ng of NGF using the time-course evaluation (2 and 7 days). The asterisk shows significant differences compared with the control group (hDPSCs) with the same antibody (P\<0.05).\
hDPSCs: Human Dental Pulp Stem Cells; NF 160: Neurofilament 160; MAP2: Microtubule-Associated Protein 2](BCN-10-609-g003){#F3}

The differentiation of hDPSCs into ChAT-positive cells was optimized at 50 ng/mL of NGF at the end of the seventh day ([Figure 3](#F3){ref-type="fig"}) when the viability was recorded about 77.7% ([Figure 2](#F2){ref-type="fig"}). On the seventh day of the induction phase, the expression rate of ChAT-positive cells increased to 71.66% compared with preinduction phase and the second day of induction, which was in favor of differentiation into cholinergic neurons (P\<0.05; [Figure 3](#F3){ref-type="fig"}). This result showed a significant difference in differentiation into cholinergic neurons.

The percentages of the induced cells were 21.66%, 78.81%, and 71.66% for nestin, NF160, MAP2, and ChAT, respectively ([Figure 4](#F4){ref-type="fig"}). On the second and seventh days of induction, the cells were stained with cresyl fast violet, which showed the neural phenotype of the induced cells ([Figure 4](#F4){ref-type="fig"}).

![Photomicrographs of hDPSCs for specific neural markers\
A, B, C, D, E, and F. Represent the third passage, nestin, NF160, MAP2, ChAT, and cresyl violet staining, respectively. Nuclei were counterstained with propidium iodide (Scale bars: 50 μm).\
hDPSCs: Human Dental Pulp Stem Cells; NF 160: Neurofilament 160; MAP2: Microtubule-Associated Protein 2](BCN-10-609-g004){#F4}

4.. Discussion
==============

Given the limited number of endogenous NSCs (Shi et al., 2011; [@B13]) and the inability of the central nervous system to repair, the generated cells can be a feasible source for replacement therapy (Shi et al., 2011; [@B13]; [@B45]; [@B37], [@B12]). Two preinduction methods have been proposed to improve the differentiation process. The NF68 and nestin are expressed in the early stages of neuron differentiation, followed by MAP2 and NF160 ([@B11]). The results of using the βME in preinduction indicated that in this stage, the cells are neuroblasts ([@B39]; [@B31]). The MAP2 marker is located on both sides of the pre-synapse and postsynapse ([@B30]). The MAP2 expression profiles in preinduction indicated that the cells were not fully differentiated in this stage ([@B14]) and were immature. The MAP2 and ChAT expression pattern, which were expressed significantly lower in the preinduction compared with the induction stage, is indicative of differentiation toward cholinergic-like neurons. The majority of neurons reduce the expression of the nestin during differentiation and maturation and increase the expression of neuronal markers, such as MAP2 and ChAT ([@B35]). Hung et al., found that induction of the BMSCs into a neuronal phenotype by βME is not stable ([@B5]), and after a while, the cells revert to their original status.

However, in this study, the NGF was used as an inductor after 48 h of preinduction by βME. The expression levels of the ChAT reached from 10% in the preinduction to about 72% in the induction phase. However, the NGF is a strong neuronal protective, which can protect the cell damages against the βME. On the other hand, the βME prevents neurons from oxidative stress by increasing the levels of reduced glutathione, which in turn, increases the ChAT activity and growth of neuronal redundancies ([@B40]). In an in vivo study, it was observed that the NGF enhanced expression of genes regulating the secretion of acetylcholine ([@B5]).

After the third passage, the hDPSCs develop a fibroblast-like morphology. Immunohistochemical studies have shown that isolated cells are negative for hematopoietic cell markers (CD45/CD34) and CD106. These findings are consistent with the results of other studies ([@B25]). Several studies have demonstrated the role of hDPSCs in the healing of spinal cord injury ([@B42]; [@B20]; Shi et al., 2011).

hDPSCs secrete NGF, glial cell-derived neurotrophic Factor (GDNF), Brain-Derived Neurotrophic Factor (BDNF), and BMP2 neurotrophic factors in the medium, which increase the lifespan of cells.

In another study, hDPSCs were transplanted to a rat model with severe spinal cord injury, and it was reported that hDPSCs increased axon growth by preventing apoptosis of neurons, astrocytes, and oligodendrocytes ([@B19]).

Exposure of hDPSCs to epidermal growth factor, basic fibroblast growth factor, and retinoic acid ([@B6]) or forskolin (Kiraly et al., 2011), resulted in their differentiation into neural cells and expressed neuronal markers ([@B6]). By injection of differentiated hDPSCs into the cerebrospinal fluid of rats, they integrated into the damaged brain parenchyma and survived for 4 weeks, where they expressed neuronal markers, including NeuN ([@B24]). The hDPSCs secrete the Vascular Endothelial Growth Factor (VEGF) and Platelet-Derived Growth Factor (PDGF) ([@B42]; [@B36]). The NGF plays a vital role in axons and neurons growth, whereas the BDNF and PDGF are essential factors for neuroprotection ([@B36]).

Based on transplantation studies, injection of hDPSCs into the healthy brain can stimulate the migration and proliferation of endogenous NSCs and increases the expression of the ciliary neurotrophic factor, VEGF, and FGF in the transplanted site ([@B25]). Although the graft has a very short lifespan, this study showed that the hDPSCs affect the adjacent cells through factors.

5.. Conclusion
==============

In an experimental model of Parkinson disease, hDPSCs were cultured and transplanted into experimental model of Parkinson. The death rate of neurons and cytotoxicity declined due to the expression of the NGF, GDNF, and BDNF by the hDPSCs ([@B34]). After the hDPSCs injection in the spinal cord injury, these cells did not differentiate into neurons but increased the lifespan of neurons and glia in the injury site and its surrounding environment ([@B44]). Axons in the spinal cord injury grew underneath the lesion site in addition to repair the scar. This axonal growth was accompanied by improved motor function after the hDPSCs injection, which was more than other cells, such as the BMSCs and ADSCs ([@B47]; [@B50]; [@B48]; [@B26]). The results of this study showed that using NGF, as an inducer, hDPSCs can differentiate into cholinergic neurons, which can be used for cytotherapy in degenerative diseases of the nervous system and spinal cord injury.
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